QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 527 in last 24h · 103,484 total before filter · latest 35m ago
527last 24h
2508last 7d
482● bullish (7d)
256● bearish (7d)
197publishers
AllMacro242Earnings1478M&A140Regulatory16Product4Analyst29
✕ clear all filtersticker: ^GSPCsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com3h agobullish
Shopify surges, AMD slides premarket as earnings disappoint

Investing.com - U.S. stock index futures were broadly higher on Wednesday as investors drew cautious optimism from signs that negotiations to reopen the Strait of Hormuz could be gaining traction, although disappointing reactions to earnings from Advanced Micro Devices and privately held SpaceX tempered enthusiasm for technology shares.

CVS’s Turnaround Faces Its Next Test
Barrons.com19h agobullish
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?
Barrons.com5d agobullish
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.

Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street
Barrons.com7d agobullish
Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.